⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRNA News
Moderna, Inc. Common Stock
Digital Champions CEE 2026: Celková hodnota se blíží 128 miliardám dolarů; region proměňují deeptech firmy a přesuny sídel společností
prnewswire.com
GOOG
MSFT
AMZN
NVDA
META
IBM
INTC
AMD
AVGO
CRM
CSCO
ADBE
ORCL
NFLX
CMCSA
DIS
BA
GD
LMT
RTX
HON
GE
CAT
DE
MMM
PG
JNJ
PFE
MRK
ABBV
BMY
GILD
AMGN
LLY
VRTX
REGN
BIIB
ALGN
ISRG
TDOC
EXPE
BKNG
AAPL
TSLA
GM
F
RIVN
LCID
NIO
XPEV
LI
PLTR
SNOW
CRWD
DDOG
PANW
MDB
PYPL
COIN
UPST
SOFI
HOOD
CRSP
EDIT
NTLA
BNTX
MRNA
NVAX
XOM
CVX
SHEL
T
VZ
TMUS
QCOM
MU
WDC
SE
BABA
JD
PDD
BIDU
NTES
GOOGL
Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028
accessnewswire.com
MRNA
XBOW Named Winner in Fast Company’s 2026 World Changing Ideas Awards
businesswire.com
MSFT
MRNA
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
globenewswire.com
TSLA
AAPL
NVDA
AMZN
META
GOOGL
NFLX
COIN
MSFT
DIS
XOM
JPM
AMD
PYPL
MRNA
MSTR
SNOW
ABNB
BABA
TSM
SMCI
PLTR
MARA
CVNA
HOOD
BRK.B
DKNG
RBLX
RDDT
GME
HIMS
CRCL
Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome
accessnewswire.com
MRNA
Happening Next Week! C-Level Technology Leadership and the Rise of Iconic Leaders Will Shape the Conversation at HMG Strategy’s 2026 New York CISO Summit. Be a Part of It. Register Now.
globenewswire.com
MSFT
PFE
BAC
CVS
FMS
DGX
VRTX
CMCSA
LAB
AMZN
GOOGL
NVDA
IBM
ORCL
AMD
INTC
META
ADBE
CRM
CSCO
ACN
TMO
UNH
JNJ
PG
XOM
CVX
KO
PEP
DIS
NFLX
TSLA
REGN
GILD
AMGN
BMY
MRNA
BIIB
CRSP
ROKU
DDOG
SNOW
PANW
ZS
CRWD
SMCI
ASML
QCOM
AMAT
MU
LRCX
KLAC
NXPI
ON
ADI
TXN
MCHP
AVGO
MRVL
PLTR
UPST
COIN
SOFI
PLUG
FCEL
SPCE
GOOG
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
globenewswire.com
RVMD
MRNA
SRPT
Moderna to Present at Upcoming Conference in June 2026
accessnewswire.com
MRNA
Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus
accessnewswire.com
MRNA
Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting
accessnewswire.com
MRNA
MRK